Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-12182 in Open-angle Glaucoma or Ocular Hypertension
NCT00069706Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2003
- Primary completion
- Oct 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of AL-12182 in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jul 2003; status: completed.
02
Drugs
AL-12182
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00069706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069706.